Delivery Order SPE2DB22D3011-SPE2DB24FQ2WM

Award Date 7/27/24
Potential Completion Date 7/29/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,078.65 firm fixed-price delivery order is for the supply of 4,568,150,874 units of Erythromycin 0.5% eye ointment in 3.5 gram packages. The award has an ultimate completion date of May 7, 2025. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,143.18 firm fixed-price delivery order is for the supply of Erythromycin 0.5% eye ointment, a 3.5 gram prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,188.80 firm fixed price delivery order is for the supply of 4565427156 - Erythromycin 0.5% Eye Ointment 3.5GM, with a completion date of August 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,439.31 firm fixed-price delivery order is for the supply of 4,566,688,703 units of Erythromycin 0.5% eye ointment in 3.5 gram tubes. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. This delivery order is part of a larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,039.76, is for the delivery of Erythromycin 0.5% eye ointment in 3.5 gram tubes. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 27, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
This federal contract award, valued at $1,833.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% Eye Ointment 3.5GM, a pharmaceutical product. The award is not designated as a set-aside contract. It is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued...
This federal contract award, valued at $1,298.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Erythromycin 0.5% Eye Ointment 3.5GM, a pharmaceutical product, with a performance period through March 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,227.19, is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $1,459.20 firm-fixed-price delivery order is for the provision of Erythromycin 0.5% eye ointment, with a completion date of May 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.92, is a Delivery Order for the procurement of ERYTHROMYCIN 0.5% EYE OINTMENT 3.5GM. The contract has an ultimate completion date of December 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2WM
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,852.42 firm fixed price delivery order is for the supply of Erythromycin 0.5% eye ointment, a critical medical product. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation. This delivery order supports the healthcare needs of military personnel and other federal beneficiaries, a key mission area for the DLA.

Generated 10/26/24, 9:21 AM